# S0511, Goserelin and Anastrozole in Treating Men With Recurrent or Metastatic Breast Cancer

> **NCT00217659** · PHASE2 · WITHDRAWN · sponsor: **SWOG Cancer Research Network**

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** anastrozole
- **DRUG:** goserelin acetate

## Key facts

- **NCT ID:** NCT00217659
- **Lead sponsor:** SWOG Cancer Research Network
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2005-09
- **Primary completion:** 2007-01
- **Final completion:** 2007-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** poor accrual
- **Last updated:** 2013-01-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00217659

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00217659, "S0511, Goserelin and Anastrozole in Treating Men With Recurrent or Metastatic Breast Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00217659. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*